female patient. Digestion 1997; 58:83.647 647. Etter JL, Moysich K, Kohli S, et al. Transmission of X‐linked ovarian cancer: characterization and implications. Diagnostics (Basel) 2020; 10:90.
648 648. Warshawsky I, Rudick RA, Staugaitis SM, et al. Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutation. Ann Neurol 2005; 58:470.
649 649. Kaplan J, Pelet A, Hentari H, et al. Contribution to carrier detection and genetic counseling in X linked retinoschisis. J Med Genet 1991; 28:383.
650 650. Souied E, Segues B, Ghazi I, et al. Severe manifestations in carrier females in X linked retinitis pigmentosa. J Med Genet 1997; 34:793.
651 651. Kurata K, Hosono K, Hayashi T, et al. X‐linked retinitis pigmentosa in Japan: clinical and genetic findings in male patients and female carriers. Int J Mol Sci 2019; 20:1518.
652 652. Ramocki MB, Peters SU, Tavyev YJ, et al. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Ann Neurol 2009; 66:771.
653 653. McKusick VA. Mendelian inheritance in man, 11th edn. Baltimore, MD: Johns Hopkins University Press, 1994: 2530.
654 654. Sajorda BJ, Gonzalez‐Gandolfi CX, Hathaway ER, et al. Simpson‐Golabi‐Behmel syndrome type 1. GeneReviews® Seattle (WA): University of Washington, Seattle, 1993–2020, 2006 [updated 2018 Nov 29].
655 655. Ishihara H, Kanda F, Nishio H, et al. Clinical features and skewed X‐chromosome inactivation in female carriers of X‐linked recessive spinal and bulbar muscular atrophy. J Neurol 2001; 248:856.
656 656. Ahmad M, Abbas H, Haque S, et al. X‐chromosomally inherited split‐hand/split foot anomaly in a Pakistani kindred. Hum Genet 1987; 75:169.
657 657. McKusick VA. Mendelian inheritance in man, 11th edn. Baltimore, MD: Johns Hopkins University Press, 1994: 2535.
658 658. van den Berghe H, Dequeker J, Fryns JP, et al. Familial occurrence of severe ulnar aplasia and lobster claw feet: a new syndrome. Hum Genet 1978; 42:109.
659 659. Wengler G, Gorlin JB, Williamson JM, et al. Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott–Aldrich syndrome. Blood 1995; 85:2471.
660 660. Peacocke M, Siminovitch KA. The Wiskott–Aldrich syndrome. Semin Dermatol 1993; 12:247.
661 661. Ziats CA, Schwartz CE, Gecz J, et al. X‐linked intellectual disability: phenotypic expression in carrier females. Clin Genet 2019; 97:418.
662 662. Uliana V, Bonatti F, Zanatta V, et al. Spectrum of X‐linked intellectual disabilities and psychiatric symptoms in a family harbouring a Xp22.12 microduplication encompassing the RPS6KA3 gene. J Genet 2019; 98:10.
663 663. Jackson MR, Loring KE, Homan CC, et al. Heterozygous loss of function of IQSEC2/Iqsec2 leads to increased activated Arf6 and severe neurocognitive seizure phenotype in females. Life Sci Alliance 2019; 2:e.201900386.
664 664. Stoll C, Geraudel A, Chauvin A. New X‐linked syndrome of mental retardation, short stature and hypertelorism. Am J Med Genet 1991; 39:474.
665 665. Atkin JF, Flaitz K, Patil S, et al. A new X‐linked mental retardation syndrome. Am J Med Genet 1985; 21:697.
666 666. Barresi S, Tomaselli S, Athanasiadis A, et al. Oligophrenin‐1 (OPHN1), a gene involved in X‐linked intellectual disability, undergoes RNA editing and alternative splicing during human brain development. PLoS One 2014; 9:e91351.
667 667. Al‐Owain M, Kaya N, Al‐Zaidan H, et al. Novel intragenic deletion in OPHN1 in a family causing XLMR with cerebellar hypoplasia and distinctive facial appearance. Clin Genet 2011; 79:363.
668 668. Dowling JJ, Lawlor MW, Das S. X‐linked myotubular myopathy. GeneReviews® Seattle (WA): University of Washington, Seattle, 1993–2020, 2002 [updated 2018 Aug 23].
669 669. Brancaleoni V, Balwani M, Granata F, et al. X‐chromosomal inactivation directly influences the phenotypic manifestation of X‐linked protoporphyria. Clin Genet 2016; 89:20.
670 670. Nowakowski R. Ocular manifestations in female carriers of X‐linked disorders. J Am Optom Assoc 1995; 66:352.
671 671. Mornet E, Chateau C, Taillandier A, et al. Recurrent and unexpected segregation of the FMR1 CGG repeat in a family with fragile X syndrome. Hum Genet 1996; 97:512.
672 672. Bowling KM, Thompson ML, Amaral MD, et al. Genomic diagnosis for children with intellectual disability and/or developmental delay. Genome Med 2017; 9:43.
673 673. Sun Y, Ruivenkamp CAL, Hoffer MJV, et al. Next‐generation diagnostics: gene panel, exome, or whole genome? Hum Mutat 2015; 36:648.
674 674. Vissers LELM, Gilissen C, Veltman JA. Genetic studies in intellectual disability and related disorders. Nat Rev Genet 2016; 17:9.
675 675. Mir YR, Kuchay RAH. Advances in identification of genes involved in autosomal recessive intellectual disability: a brief review. J Med Genet 2019; 56:567.
676 676. Linstrand A, Eisfeldt J, Pettersson M, et al. From cytogenetics to cytogenomics: whole‐genome sequencing as a first‐line test comprehensively captures the diverse spectrum of disease‐causing genetic variation underlying intellectual disability. Genome Med 2019; 11:68.
677 677. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first‐tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86(5):749.
678 678. Waggoner D, Wain KE, Dubuc AM, et al. Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2018; 20(10):1105.
679 679. Clark DW, Okada Y, Moore KHS, et al. Associations of autozygosity with a broad range of human phenotypes. Nat Commun 2019; 10:4957.
680 680. Abdulrazzaq YM, Bener A, Al‐Gazali LI, et al. A study of possible deleterious effects of consanguinity. Clin Genet 1997; 51:167.
681 681. Saadallah AA, Rashed MS. Newborn screening: experiences in the Middle East and North Africa. J Inherit Metab Dis 2007; 30:482.
682 682. Bundey S, Alam H, Kaur A, et al. Race, consanguinity and social features in Birmingham babies: a basis for prospective study. J Epidemiol Commun Health 1990; 44:130.
683 683. Khoury SA, Massad DF. Consanguinity, fertility, reproductive wastage, infant mortality and congenital malformations in Jordan. Saudi Med J 2000; 21:150.
684 684. Stoltenberg C, Magnus P, Lie RT, et al. Birth defects and parental consanguinity in Norway. AmJ Epidemiol 1997; 145:439.
685 685. Perveen F, Tyyab S. Frequency and pattern of distribution of congenital anomalies in the newborn and associated maternal risk factors. J Coll Physicians Surg Pak 2007; 17:340.
686 686. Monies D, Abouelhoda M, Assoum M, et al. Lessons learned from large‐scale, first‐tier clinical exome sequencing in a highly consanguineous population. Am J Hum Genet 2019; 104(6):1182.
687 687. Vora NL, Gilmore K, Brandt A, et al. An approach to integrating exome sequencing for fetal structural anomalies into clinical practice. Genet Med 2020; 22(5):954.
